SRV Hospitals has raised ₹140 crore in funding from InvAscent, a life sciences-focused private equity fund.
The funds raised will be used to strengthen and amplify its multispecialty critical care-focused healthcare model.
“We built SRV Hospitals with a vision of setting new standards in the critical and surgical care space, and those standards have now become our greatest strength. This investment from InvAscent is a strategic alignment of purpose. Over these years, SRV has grown with intent, delivered excellence with consistency, and built trust with one patient, one family, and one neighbourhood at a time. This capital will strengthen our core and extend our impact,” said Dr Abhay Vispute, Director – SRV Hospitals.
Sameer Pawar, CEO, SRV Hospitals, said, “Our mission is rooted in the belief that high-quality care should not be a privilege of geography. We’ve created hospital ecosystems that bring empathy, expertise, and innovation to people’s neighbourhoods. This investment allows us to strengthen our mission responsibly—with our people, our standards, and our commitment to trust at the centre of it all.”
“We are proud to partner with SRV Hospitals, a group that has a strong foundation and boasts a high-trust clinical network backed by a differentiated critical care model, and a leadership team that is not only clinically astute and operationally strong but deeply aligned with the long-term evolution of healthcare in this country,” said Dr Jeevak Gupta, Director – Investments, InvAscent.
Founded in 2015, SRV Hospitals offers a wide range of specialities, including critical care, surgery, cardiology, orthopaedics, oncology, and more. Currently operating five advanced hospitals across Mumbai, Nashik, and Bengaluru with a combined capacity of 500+ beds.
InvAscent has previously backed top healthcare brands like HCG Hospitals and Dr Agarwal’s Eye Hospital.
